GlassScriptPhysician profile
Randall Ball
NPI 1972567451
$4,384.41
in general payments reported to CMS, 2019-2025
41 companies · $1,245 in 2025
The $1,245 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,059 · 2022: $944 · 2024: $1,137 · 2025: $1,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,283 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,282.80 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $562.66 | 2021-2022 | |
| Abbvie INC. | $501.92 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $372.03 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $321.35 | 2021-2025 | Tagrisso, Breztri, Lynparza |
| Biohaven Pharmaceuticals, INC. | $236.35 | 2021 | |
| Novartis Pharmaceuticals Corporation | $234.64 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $212.00 | 2021-2025 | Fruzaqla, Ninlaro |
| Janssen Biotech, INC. | $185.79 | 2024-2025 | Rybrevant, Erleada, Darzalex |
| Daiichi Sankyo INC. | $167.33 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Glaxosmithkline, LLC. | $118.07 | 2021-2022 | |
| Lilly USA, LLC | $115.34 | 2021-2025 | Jaypirca, Verzenio |
| Incyte Corporation | $109.04 | 2024-2025 | Jakafi |
| Seagen INC. | $99.00 | 2024 | |
| Eisai INC. | $92.68 | 2024-2025 | |
| Astellas Pharma US INC | $92.67 | 2021-2025 | Xtandi, Padcev |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.